Compare NMRA & LZM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | NMRA | LZM |
|---|---|---|
| Founded | 2019 | 2021 |
| Country | United States | Isle of Man |
| Employees | N/A | 93 |
| Industry | | Metal Mining |
| Sector | | Basic Materials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 554.0M | 460.6M |
| IPO Year | 2023 | N/A |
| Metric | NMRA | LZM |
|---|---|---|
| Price | $1.72 | $5.13 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 8 | 1 |
| Target Price | ★ $7.50 | $7.00 |
| AVG Volume (30 Days) | ★ 1.2M | 551.5K |
| Earning Date | 05-07-2026 | 03-19-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 5.23 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $86.37 |
| Revenue Next Year | N/A | $202.49 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.72 | $3.07 |
| 52 Week High | $3.65 | $6.40 |
| Indicator | NMRA | LZM |
|---|---|---|
| Relative Strength Index (RSI) | 37.66 | 50.45 |
| Support Level | $1.67 | $4.15 |
| Resistance Level | $1.95 | $6.15 |
| Average True Range (ATR) | 0.13 | 0.37 |
| MACD | 0.01 | 0.01 |
| Stochastic Oscillator | 15.38 | 47.47 |
Neumora Therapeutics Inc is a clinical-stage biopharmaceutical company founded to confront the brain disease crisis by taking a fundamentally different approach to the way treatments for brain diseases are developed. It has scaled its therapeutic pipeline, which currently consists of seven clinical and preclinical neuroscience programs that target novel mechanisms of action for a broad range of underserved neuropsychiatric disorders and neurodegenerative diseases. Its pipeline includes NMRA-140, NMRA-511, NMRA-266, NMRA-M4R, NMRA-NMDA, NMRA-CK1O, NMRA-NLRP3, and NMRA-GCASE. The group's pipeline is building programs for underserved neuropsychiatric disorders and neurodegenerative diseases.
Lifezone Metals Ltd seeks to support the clean energy transition through the licensing of Hydromet Technology as an alternative to smelting and metals refining. Its business comprises three segments: Metals extraction and refining for developing and operating a vertically integrated base metal operation in the northwest region of Tanzania, and Intellectual property licensing comprises patents residing with and managed by the subsidiary and corporate. Geographically, the company operates in South Africa, Australia, and the rest of the world. The majority of its revenue is generated from Australia.